Analyst Price Target is $130.07
▲ +43.84% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Loblaw Companies in the last 3 months. The average price target is $130.07, with a high forecast of $160.00 and a low forecast of $116.00. The average price target represents a 43.84% upside from the last price of $90.43.
Current Consensus is
The current consensus among 1 investment analysts is to hold stock in Loblaw Companies. This rating changed within the last month from a Buy consensus rating.
Loblaw Companies Limited, a food and pharmacy company, engages in the grocery, pharmacy, health and beauty, apparel, general merchandise, financial services, and wireless mobile products and services businesses in Canada. It operates in two segments, Retail and Financial Services. The Retail segment operates corporate and franchise-owned retail food, and associate-owned drug stores. This segment also includes in-store pharmacies, other health and beauty product stores, apparel stores, and other general merchandise stores. The Financial Services segment provides credit card and banking services, the PC Optimum program, insurance brokerage services, and telecommunication services. It also offers PC Health app, a health and wellness app that provides Canadians with access to healthcare resources and support. Loblaw Companies Limited provides its products and services under various brands. The company was founded in 1919 and is headquartered in Brampton, Canada. Loblaw Companies Limited operates as a subsidiary of George Weston Limited.